Lurasidone Market

Lurasidone Market Size, Share & Industry Analysis, By Source (Synthetic Organic Synthesis, Biotechnology Processes), By Application (Schizophrenia Treatment, Bipolar Disorder Treatment, Other Psychiatric Disorders), Key End-User Industry (Pharmaceuticals, Hospitals & Healthcare Centers, Research & Development, Drug Manufacturers), and Forecast, 2025–2035

The Lurasidone market is projected to grow at a steady CAGR of 4.9% between 2025 and 2035, driven by the increasing incidence of mental health disorders such as schizophrenia and bipolar disorder. Growing awareness of psychiatric conditions and rising demand for second-generation antipsychotics are fueling market demand. Lurasidone’s efficacy, favorable side-effect profile, and its inclusion in long-term maintenance therapies support its uptake in the pharmaceutical industry.

Regionally, North America dominates the Lurasidone API market owing to high diagnosis rates of psychiatric disorders, supportive reimbursement systems, and strong API manufacturing infrastructure. Europe follows with steady growth supported by mental health initiatives and expanding use of generic APIs. Certainly, the Asia-Pacific region is expected to witness the fastest growth, led by India and China’s manufacturing capacities and growing regional demand for psychiatric treatments.

The market benefits from increasing psychiatric drug pipelines, patent expirations leading to generic API demand, and supportive government funding for mental health. Challenges include pricing pressures, regulatory hurdles in approval, and stringent quality standards for psychiatric drug ingredients. Nonetheless, growing mental health burdens globally ensure consistent market traction.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

Introduction

Overview of Lurasidone
Key Applications & Industry Use Cases
Market Scope & Study Objectives

Market Overview

Global Market Size & Growth Trends (Historical & Forecast)
Market Value & Revenue Analysis
Demand-Supply Dynamics

Segmental Outlook

By Source
- Synthetic Organic Synthesis
- Biotechnology Processes
By Application
- Schizophrenia Treatment
- Bipolar Disorder Treatment
- Other Psychiatric Disorders
Key End-User Industry
- Pharmaceuticals
- Hospitals & Healthcare Centers
- Research & Development
- Drug Manufacturers

Price Analysis

Current Price Trends (Per kg & Per Ton)
Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)

Production & Supply Volume

Global Production Capacity & Key Manufacturers
Production Process & Technological Developments
Raw Material Analysis

Trade Analysis (Import & Export)

Major Exporting & Importing Countries
Trade Volume & Value Statistics
Impact of Trade Regulations & Policies

Regional Analysis

North America (US and Canada)
Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
Rest of the World (Latin America, Middle East, and Africa)

Competitive Landscape

Top Global Manufacturers & Market Share
Company Profiles & Key Developments
Mergers, Acquisitions & Investments

Regulatory & Compliance Factors

FDA, REACH, and Other Regulatory Frameworks
Environmental & Safety Considerations
Emerging Policies Impacting Market Growth

Conclusion & Strategic Recommendations

Key Takeaways for Stakeholders
Market Entry Strategies

May 12, 2025

What is Lurasidone?

Lurasidone is an atypical antipsychotic medication primarily used for the treatment of schizophrenia and bipolar depression. It works by modulating the effects of neurotransmitters such as dopamine and serotonin in the brain.

What is the market size for Lurasidone?

Lurasidone is growing at a CAGR of 4.9% during the forecast period of 2025-2035, supported by rising demand for mental health treatments and expanding generic drug manufacturing.

What are the drivers for the Lurasidone Market?

Key drivers include the increasing global burden of schizophrenia and bipolar disorder, growing awareness and diagnosis of psychiatric conditions, and rising demand for cost-effective second-generation antipsychotics.

Who are the key players operating in the Lurasidone Market?

Major players include Sumitomo Pharma Co., Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Aurobindo Pharma, Zydus Lifesciences, and Torrent Pharmaceuticals.

Which region would exhibit the fastest growth in the Lurasidone Market?

The Asia-Pacific region is expected to exhibit the fastest growth in the Lurasidone API market owing to expanding pharmaceutical manufacturing in countries like India and China. Increasing mental health awareness and growing healthcare infrastructure further drive regional demand.

$1800/- Single User License
$3600/- Multi User License

Experienced in market research and consulting.
Seasoned professionals with diverse industry knowledge.
Proven track record in delivering valuable insights.
Tailored methodologies for unique client needs.
End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
Latest tools and tech for data collection, analysis, and visualization.
Embrace of AI and machine learning for deeper insights.
Global capabilities and extensive network.
In-depth understanding of international markets, trends, and regulations.
Dedicated to addressing specific client needs and goals.
Focus on delivering value through efficient research outcomes.

How can we help you?

Reach out to discuss how our team can help your business achieve real results.

Contact Person

Mr. Anurag Tiwari

Call Us

+91-780-304-0404

Mail Us

info@omrglobal.com